domain | biomia.com |
summary | The provided content is a summary:
- There are issues related to CNS (central nervous system) disorders affecting around 1.5 billion people globally. - The current medications like morphine used for these conditions do not effectively treat certain types of pain such as chronic and neuropathic, leading to tolerance, respiratory depression, or even addiction.
- Many of the central neurotherapeutics are derived from nature but have side effects that can be potentially devastating.
- In addition, 3.0 million in pre-seed financing has been secured by Biomia for research into this issue and other related projects including a microbial supply chain to produce an anti-cancer drug called vinblastine.
- The organization is also considering the implementation of new roles such as Chief Scientific Officer (1) and Chief Technology Officer, following its recent appointment.
- An iterative design-build-test-learn approach in bioengineering using open-source programming has been considered for research. This content also includes a number of news or announcement related to various publications including nature-derived therapeutics on different issues like the synthesis of certain plant monoterpene indole alkaloids and work with mechanisms, machine learning models. |
title | Biomia |
description | Biomia rationally engineers nature-inspired novel small molecule therapeutics to treat CNS disorders. |
keywords | nature, news, drug, biology, journal, therapeutics, yeast, pain, team, disorders, optimization, engineering, publications, patents, expert, chief, officer |
upstreams |
|
downstreams |
|
nslookup | A 75.2.70.75, A 99.83.190.102 |
created | 2025-05-31 |
updated | 2025-05-31 |
summarized | 2025-06-02 |
|
|